Aliment Pharmacol Ther 2010; 32: 1069–1079 Summary Background Problems with
currently recommended Helicobacter pylori eradication therapies include unsatisfactory …

Summary Background Unsatisfactory Helicobacter pylori eradication rates and therapy‐
associated side effects remain a problem. Aim To update our 2010 meta‐analysis on the …

Abstract Background and Aims Whether Saccharomyces boulardii (S boulardii) as an
adjuvant therapy are beneficial to H pylori eradication remains controversial. The aim of the …

Background: Recent studies indicate a potential role of Saccharomyces boulardii in the
prevention of Helicobacter pylori treatment‐related side‐effects and also in improvement of …

Aim: The failure rate of Helicobacter pylori (H. pylori) eradication imposes the assessment of
new options. Subjects and methods: A prospective open study was performed in 90 …

Methods In a multicentre prospective clinical trial, patients with peptic ulcer disease or non-
ulcer dyspepsia were enrolled to receive clarithromycin, amoxicillin and omeprazole for H …

Aim To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication
rates and side effects of the triple therapy. Methods PubMed, Embase, Web of Science and …

AIM To define probiotic monotherapy effect on Helicobacter pylori (H. pylori) status by
performing a systematic review. METHODS Methods of analysis and inclusion criteria were …

Therapy-related side effects and severe antimicrobial resistance still remain an obstacle to
Helicobacter pylori eradication. This meta-analysis aimed to investigate the efficacy of …

Background Traditional Helicobacter pylori (H. pylori) eradication therapies have shown
efficacies below 80% in several studies, and their use has been accompanied by antibiotic …